2010 European guideline for the management of Chlamydia trachomatis infections

International Journal of STD and AIDS

Volumn 21, Issue 11, 2010, Pages 729-737

  Lanjouw, E ^a   Ossewaarde, J M ^a,b   Stary, A ^c   Boag, F ^d   Van Der Meijden, W I ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Maasstad Hospital   (Netherlands)

^c Outpatients' Centre for Infectious Venereodermatological Diseases   (Austria)

^d CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e Havenziekenhuis   (Netherlands)

Author keywords

Chlamydia trachomatis; Diagnostics; Follow up; Guidelines; Treatment; Urogenital infections

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; MACROLIDE; RIFAMPICIN;

BACTERIAL LOAD; CELL CULTURE; CHLAMYDIASIS; CLINICAL FEATURE; CONCURRENT INFECTION; ECTOPIC PREGNANCY; ENDOMETRITIS; ENZYME IMMUNOASSAY; EUROPE; FLUORESCENCE ANALYSIS; GONORRHEA; HUMAN; INFERTILITY; LYMPHOGRANULOMA VENEREUM; MEDICAL STAFF; META ANALYSIS (TOPIC); MYCOPLASMA GENITALIUM; NEWBORN INFECTION; NUCLEIC ACID AMPLIFICATION; PAPANICOLAOU TEST; PELVIC INFLAMMATORY DISEASE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCTITIS; QUALITY CONTROL; REACTIVE ARTHRITIS; REVIEW; SALPINGITIS; SEMEN ANALYSIS; SEROLOGY; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; URINALYSIS; VAGINA SMEAR;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EUROPE; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; PRACTICE GUIDELINES AS TOPIC; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 78650811698     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2010.010302     Document Type: Review

References (135)

1. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999;49(Pt 2):415-40
2. Markos AR. The concordance of Chlamydia trachomatis genital infection between sexual partners, in the era of nucleic acid testing. Sex Health 2005;2:23-4
3. Johnson BA, Poses RM, Fortner CA, Meier FA, Dalton HP. Derivation and validation of a clinical diagnostic model for chlamydial cervical infection in university women. JAMA 1990;264:3161-5
4. McCormack WM, Rosner B, McComb DE, Evrard JR, Zinner SH. Infection with Chlamydia trachomatis in female college students. Am J Epidemiol 1985;121:107-15
5. McNagny SE, Parker RM, Zenilman JM, Lewis JS. Urinary leukocyte esterase test: a screening method for the detection of asymptomatic chlamydial and gonococcal infections in men. J Infect Dis 1992;165:573-6
6. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005;41:67-74
7. Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005;16:235-44
8. Cates W Jr, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771-81
9. Hillis SD, Wasserheit JN. Screening for chlamydia - a key to the prevention of pelvic inflammatory disease. N Engl J Med 1996;334:1399-401
10. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997;176:103-7
11. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. World Health Organization Task Force on the Prevention and Management of Infertility. Sex Transm Dis 1995;22:71-7
12. Ross J, Judlin P, Nilas L. European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2007;18:662-6
13. Bezold G, Politch JA, Kiviat NB, Kuypers JM, Wolff H, Anderson DJ. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007;87:1087-97
14. Greendale GA, Haas ST, Holbrook K, Walsh B, Schachter J, Phillips RS. The relationship of Chlamydia trachomatis infection and male infertility. Am J Public Health 1993;83:996-1001
15. Joki-Korpela P, Sahrakorpi N, Halttunen M, Surcel HM, Paavonen J, Tiitinen A. The role of Chlamydia trachomatis infection in male infertility. Fertil Steril 2009;91:1448-50
16. Pearson RC, Baumber CD, McGhie D, Thambar IV. The relevance of Chlamydia trachomatis in acute epididymitis in young men. Br J Urol 1988;62:72-5
17. Kaneti J, Sarov B, Sarov I. IgG and IgA antibodies specific for Chlamydia trachomatis in acute epididymitis. Eur Urol 1988;14:323-7
18. Eley A, Oxley KM, Spencer RC, Kinghorn GR, Ben-Ahmeida ET, Potter CW. Detection of Chlamydia trachomatis by the polymerase chain reaction in young patients with acute epididymitis. Eur J Clin Microbiol Infect Dis 1992;11:620-3
19. De Jong Z, Pontonnier F, Plante P, et al. The frequency of Chlamydia trachomatis in acute epididymitis. Br J Urol 1988;62:76-8
20. Nieuwenhuis RF, Ossewaarde JM, Gotz HM, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 2004;39:996-1003
21. van de Laar MJ, Fenton KA, Ison C. Update on the European lymphogranuloma venereum epidemic among men who have sex with men. Euro Surveill 2005;10:E050602
22. Ward H, Martin I, Macdonald N, et al. Lymphogranuloma venereum in the United kingdom. Clin Infect Dis 2007;44:26-32
23. Kazal HL, Sohn N, Carrasco JI, Robilotti JG, Delaney WE. The gay bowel syndrome: clinico-pathologic correlation in 260 cases. Ann Clin Lab Sci 1976;6:184-92
24. Quinn TC, Goodell SE, Mkrtichian E, et al. Chlamydia trachomatis proctitis. N Engl J Med 1981;305:195-200
25. Forrester B, Pawade J, Horner P. The potential role of serology in diagnosing chronic lymphogranuloma venereum (LGV): a case of LGV mimicking Crohn's disease. Sex Transm Infect 2006;82:139-40
26. McMillan A, Kell P, Ward H. Diagnosing chlamydia and managing proctitis in men who have sex with men: current UK practice. Sex Transm Infect 2008;84:97-100 (Pubitemid 351497917)
27. McMillan A, van Voorst Vader PC, de Vries HJC. The 2007 European Guideline (International Union against Sexually Transmitted Infections/World Health Organization) on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS 2007;18:514-20
28. Watson EJ, Templeton A, Russell I, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002;51:1021-31
29. Hadgu A, Dendukuri N, Hilden J. Evaluation of nucleic acid amplification tests in the absence of a perfect gold-standard test: a review of the statistical and epidemiologic issues. Epidemiology 2005;16:604-12
30. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25
31. Levett PN, Brandt K, Olenius K, Brown C, Montgomery K, Horsman GB. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J Clin Microbiol 2008;46:2109-11
32. Morré SA, Ouburg S, van Agtmael MA, de Vries HJ. Lymphogranuloma venereum diagnostics: from culture to real-time quadriplex polymerase chain reaction. Sex Transm Infect 2008;84:252-3
33. Pickett MA, Everson JS, Pead PJ, Clarke IN. The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents. Microbiology 2005;151:893-903
34. Comanducci M, Ricci S, Cevenini R, Ratti G. Diversity of the Chlamydia trachomatis common plasmid in biovars with different pathogenicity. Plasmid 1990;23:149-54 (Pubitemid 20202914)
35. Pearce BJ, Fahr MJ, Hatch TP, Sriprakash KS. A chlamydial plasmid is differentially transcribed during the life cycle of Chlamydia trachomatis. Plasmid 1991;26:116-22
36. Peterson EM, Markoff BA, Schachter J, de la Maza LM. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid 1990;23:144-8 (Pubitemid 20202913)
37. Farencena A, Comanducci M, Donati M, Ratti G, Cevenini R. Characterization of a new isolate of Chlamydia trachomatis which lacks the common plasmid and has properties of biovar trachoma. Infect Immun 1997;65:2965-9
38. Magbanua JP, Goh BT, Michel CE, et al. Chlamydia trachomatis variant not detected by plasmid based nucleic acid amplification tests: molecular characterisation and failure of single dose azithromycin. Sex Transm Infect 2007;83:339-43
39. Matsumoto A, Izutsu H, Miyashita N, Ohuchi M. Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J Clin Microbiol 1998;36:3013-9
40. An Q, Radcliffe G, Vassallo R, et al. Infection with a plasmid-free variant Chlamydia related to Chlamydia trachomatis identified by using multiple assays for nucleic acid detection. J Clin Microbiol 1992;30:2814-21
41. An Q, Olive DM. Molecular cloning and nucleic acid sequencing of Chlamydia trachomatis 16S rRNA genes from patient samples lacking the cryptic plasmid. Mol Cell Probes 1994;8:429-35
42. Ripa T, Nilsson PA. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill 2006;11:E061109
43. Ripa T, Nilsson PA. A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex Transm Dis 2007;34:255-6 (Pubitemid 46707474)
44. Herrmann B. A new genetic variant of Chlamydia trachomatis. Sex Transm Infect 2007;83:253-4 (Pubitemid 47242499)
45. Catsburg A, van Dommelen L, Smelov V, et al. TaqMan assay for Swedish Chlamydia trachomatis variant. Emerg Infect Dis 2007;13:1432-4
46. Savage EJ, Ison CA, van de Laar MJ. Results of a Europe-wide investigation to assess the presence of a new variant of Chlamydia trachomatis. Euro Surveill 2007;12:E3-E4
47. Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Transm Dis 2008;35:S45-50
48. Marrazzo JM, Scholes D. Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review. Sex Transm Dis 2008;35:S28-33
49. Fang J, Husman C, DeSilva L, Chang R, Peralta L. Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females. J Pediatr Adolesc Gynecol 2008;21:355-60
50. Chernesky MA, Hook EW III, Martin DH, et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transm Dis 2005;32:729-33
51. Shafer MA, Moncada J, Boyer CB, Betsinger K, Flinn SD, Schachter J. Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test. J Clin Microbiol 2003;41:4395-9
52. Schachter J, McCormack WM, Chernesky MA, et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003;41:3784-9
53. Wiesenfeld HC, Lowry DL, Heine RP, et al. Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis 2001;28:321-5
54. Wiesenfeld HC, Heine RP, Rideout A, Macio I, DiBiasi F, Sweet RL. The vaginal introitus: a novel site for Chlamydia trachomatis testing in women. Am J Obstet Gynecol 1996;174:1542-6 (Pubitemid 26165275)
55. Smith K, Harrington K, Wingood G, Oh MK, Hook EW III, DiClemente RJ. Self-obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls. Arch Pediatr Adolesc Med 2001;155:676-9 (Pubitemid 32521130)
56. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725-8 (Pubitemid 41752557)
57. Hobbs MM, van der Pol B, Totten P, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008;35:8-13
58. Michel CE, Sonnex C, Carne CA, et al. Chlamydia trachomatis load at matched anatomic sites: implications for screening strategies. J Clin Microbiol 2007;45:1395-402
59. Fitzhugh VA, Heller DS. Significance of a diagnosis of microorganisms on pap smear. J Low Genit Tract Dis 2008;12:40-51
60. Baud D, Regan L, Greub G. Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes. Curr Opin Infect Dis 2008;21:70-6
61. Blas MM, Canchihuaman FA, Alva IE, Hawes SE. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect 2007;83:314-8
62. Rastogi S, Das B, Salhan S, Mittal A. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet 2003;80:129-37 (Pubitemid 36143952)
63. Jebakumar SP, Storey C, Lusher M, Nelson J, Goorney B, Haye KR. Value of screening for oro-pharyngeal Chlamydia trachomatis infection. J Clin Pathol 1995;48:658-61
64. Elnifro EM, Storey CC, Morris DJ, Tullo AB. Polymerase chain reaction for detection of Chlamydia trachomatis in conjunctival swabs. Br J Ophthalmol 1997;81:497-500
65. Hammerschlag MR, Roblin PM, Gelling M, Tsumura N, Jule JE, Kutlin A. Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis. Pediatr Infect Dis J 1997;16:293-7
66. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008;35:637-42
67. Ota KV, Tamari IE, Smieja M, et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex Transm Infect 2009;85:182-6
68. Alexander S, Martin I, Ison C. Confirming the Chlamydia trachomatis status of referred rectal specimens. Sex Transm Infect 2007;83:327-9 (Pubitemid 47242514)
69. Annan NT, Sullivan AK, Nori A, et al. Rectal chlamydia - a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect 2009;85:176-9
70. Gdoura R, Kchaou W, Ammar-Keskes L, et al. Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl 2008;29:198-206 (Pubitemid 351345717)
71. Hamdad-Daoudi F, Petit J, Eb F. Assessment of Chlamydia trachomatis infection in asymptomatic male partners of infertile couples. J Med Microbiol 2004;53:985-90 (Pubitemid 39391966)
72. Pannekoek Y, Westenberg SM, Eijk PP, et al. Assessment of Chlamydia trachomatis infection of semen specimens by ligase chain reaction. J Med Microbiol 2003;52:777-9
73. Horner PJ, Crowley T, Leece J, Hughes A, Smith GD, Caul EO. Chlamydia trachomatis detection and the menstrual cycle. Lancet 1998;351:341-2
74. Jensen IP, Thorsen P, Moller BR. Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis. Lancet 1997;349:329-30
75. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep 2002;51:1-38
76. Chernesky MA, Jang D, Chong S, Sellors J, Mahony J. Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infections in men. Sex Transm Dis 2003;30:345-7 (Pubitemid 36397838)
77. Manavi K, Young H. The significance of voiding interval before testing urine samples for Chlamydia trachomatis in men. Sex Transm Infect 2006;82:34-6 (Pubitemid 43266158)
78. Thomas BJ, Gilchrist C, Hay PE, Taylor-Robinson D. Simplification of procedures used to test urine samples for Chlamydia trachomatis. J Clin Pathol 1991;44:374-5
79. Møller JK, Andersen B, Olesen F, Lignell T, Østergaard L. Impact of menstrual cycle on the diagnostic performance of LCR, TMA, and PCE for detection of Chlamydia trachomatis in home obtained and mailed vaginal flush and urine samples. Sex Transm Infect 1999;75:228-30
80. Chernesky MA, Jang D, Luinstra K, et al. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J Clin Microbiol 2006;44:400-5
81. Gaydos CA, Quinn TC, Willis D, et al. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003;41:304-9
82. Hamilton MS, Otto M, Nickell A, Abel D, Ballam Y, Schremmer R. High frequency of competitive inhibition in the Roche Cobas AMPLICOR multiplex PCR for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2002;40:4393
83. Scragg S, Bingham A, Mallinson H. Should Chlamydia trachomatis confirmation make you cross? Performance of collection kits tested across three nucleic acid amplification test platforms. Sex Transm Infect 2006;82:295-7
84. Schachter J, Chow JM, Howard H, Bolan G, Moncada J. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised. J Clin Microbiol 2006;44:2512-7 (Pubitemid 44092420)
85. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997;10:160-84
86. Clad A, Freidank HM, Kunze M, et al. Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur J Clin Microbiol Infect Dis 2000;19:932-7
87. Mouton JW, Peeters MF, van Rijsoort-Vos JH, Verkooyen RP. Tubal factor pathology caused by Chlamydia trachomatis: the role of serology. Int J STD AIDS 2002;13 (Suppl 2):26-9
88. Verkooyen RP, Peeters MF, van Rijsoort-Vos JH, van der Meijden WI, Mouton JW. Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests. Int J STD AIDS 2002;13 (Suppl 2):23-5
89. Land JA, Evers JL. Chlamydia infection and subfertility. Best Pract Res Clin Obstet Gynaecol 2002;16:901-12
90. Halioua B, Bohbot JM, Monfort L, et al. Ano-rectal lymphogranuloma venereum: 22 cases reported in a sexually transmited infections center in Paris. Eur J Dermatol 2006;16:177-80
91. van der Snoek EM, Ossewaarde JM, van der Meijden WI, Mulder PG, Thio HB. The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis. Sex Transm Infect 2007;83:330-4
92. Fryer JF, Minor PD. Standardisation of nucleic acid amplification assays used in clinical diagnostics: a report of the first meeting of the SoGAT Clinical Diagnostics Working Group. J Clin Virol 2009;44:103-5
93. Dimech W, Bowden DS, Brestovac B, et al. Validation of assembled nucleic acid-based tests in diagnostic microbiology laboratories. Pathology 2004;36:45-50
94. Ratcliff RM, Chang G, Kok T, Sloots TP. Molecular diagnosis of medical viruses. Curr Issues Mol Biol 2007;9:87-102
95. Gronowski AM, Copper S, Baorto D, Murray PR. Reproducibility problems with the Abbott laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2000;38:2416-8
96. Parks KS, Dixon PB, Richey CM, Hook EW, III. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis 1997;24:229-35
97. Joyner JL, Douglas JM Jr, Foster M, Judson FN. Persistence of Chlamydia trachomatis infection detected by polymerase chain reaction in untreated patients. Sex Transm Dis 2002;29:196-200
98. Somani J, Bhullar VB, Workowski KA, Farshy CE, Black CM. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000;181:1421-7 (Pubitemid 30252548)
99. Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis 2005;191:917-23
100. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002;29:497-502
101. Adimora AA. Treatment of uncomplicated genital Chlamydia trachomatis infections in adults. Clin Infect Dis 2002;35:S183-6
102. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003;30:49-56 (Pubitemid 36071086)
103. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005;352:676-85
104. Colombo U, Pifarotti G, Amidani M, Viezzoli T, Pifarotti P. Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin. Minerva Ginecol 1998;50:491-7 (Pubitemid 28550227)
105. Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents 2007;30:213-21 (Pubitemid 47126817)
106. Rahangdale L, Guerry S, Bauer HM, et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006;33:106-10
107. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand 2000;79:234-7 (Pubitemid 30119799)
108. Soltz-Szots J, Schneider S, Niebauer B, Knobler RM, Lindmaier A. Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients. Z Hautkr 1989;64:129-31
109. Steedman NM, McMillan A. Treatment of asymptomatic rectal Chlamydia trachomatis: is single-dose azithromycin effective? Int J STD AIDS 2009;20:16-8
110. McLean CA, Stoner BP, Workowski KA. Treatment of lymphogranuloma venereum. Clin Infect Dis 2007;44 (Suppl 3):S147-52
111. de Vries HJC, Smelov V, Middelburg JG, Pleijster J, Speksnijder AG, Morré SA. Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment. Clin Infect Dis 2009;48:e53-6
112. Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010;201:42-51
113. Dreses-Werringloer U, Padubrin I, Zeidler H, Kohler L. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 2001;45:3001-8
114. Bin XX, Wolf K, Schaffner T, Malinverni R. Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. Antimicrob Agents Chemother 2000;44:1761-4
115. Wolf K, Malinverni R. Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. Antimicrob Agents Chemother 1999;43:1491-3
116. Siewert K, Rupp J, Klinger M, Solbach W, Gieffers J. Growth cycle-dependent pharmacodynamics of antichlamydial drugs. Antimicrob Agents Chemother 2005;49:1852-6
117. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1-94
118. Harindra V, Tobin JM, Underhill G. Opportunistic chlamydia screening; should positive patients be screened for co-infections? Int J STD AIDS 2002;13:821-5
119. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis 2008;21:65-9
120. Ross JD. Is Mycoplasma genitalium a cause of pelvic inflammatory disease? Infect Dis Clin North Am 2005;19:407-13
121. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008;47:1546-53
122. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008;3:e3618
123. Bjornelius E, Anagrius C, Bojs G, et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008;84:72-6
124. Haggerty CL, Ness RB. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clin Infect Dis 2007;44:953-60
125. Arthur G, Lowndes CM, Blackham J, Fenton KA. Divergent approaches to partner notification for sexually transmitted infections across the European union. Sex Transm Dis 2005;32:734-41
126. Geisler WM. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010;201 (Suppl 2):S104-13
127. Wilson TE, Hogben M, Malka ES, et al. A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification. Am J Public Health 2009;99 (Suppl 1):S104-10
128. Hogben M, Kissinger P. A review of partner notification for sex partners of men infected with Chlamydia. Sex Transm Dis 2008;35:S34-9
129. Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44 (Suppl 3):S77-83
130. Hodge JG Jr, Pulver A, Hogben M, Bhattacharya D, Brown EF. Expedited partner therapy for sexually transmitted diseases: assessing the legal environment. Am J Public Health 2008;98:238-43
131. Shivasankar S, Challenor R. Patient-delivered partner therapy in the UK: what do the professionals think? Int J STD AIDS 2008;19:437-40
132. Coyne KM, Cohen CE, Smith NA, Mandalia S, Barton S. Patient-delivered partner medication in the UK: an unlawful but popular choice. Int J STD AIDS 2007;18:829-31 (Pubitemid 351738862)
133. Shivasankar S, Challenor R, Ekanayaka R. Patient-delivered partner therapy in the UK: what do patients think? Int J STD AIDS 2008;19:433-6
134. Stary A. European guideline for the management of chlamydial infection. Int J STD AIDS 2001;12 (Suppl 3):30-3
135. Deurenberg R, Vlayen J, Guillo S, Oliver TK, Fervers B, Burgers J. Standardization of search methods for guideline development: an international survey of evidence-based guideline development groups. Health Info Libr J 2008;25:23-30